Aims and scope
Addiction Science & Clinical Practice provides a forum for clinically relevant research and perspectives that contribute to improving the quality of care for people with unhealthy alcohol, tobacco, or other drug use and addictive behaviours across a spectrum of clinical settings.
Addiction Science & Clinical Practice accepts articles of clinical relevance related to the prevention and treatment of unhealthy alcohol, tobacco, and other drug use across the spectrum of clinical settings. Topics of interest address issues related to the following: the spectrum of unhealthy use of alcohol, tobacco, and other drugs among the range of affected persons (e.g., not limited by age, race/ethnicity, gender, or sexual orientation); the array of clinical prevention and treatment practices (from health messages, to identification and early intervention, to more extensive interventions including counseling and pharmacotherapy and other management strategies); and identification and management of medical, psychiatric, social, and other health consequences of substance use.
Addiction Science & Clinical Practice is particularly interested in articles that address how to improve the quality of care for people with unhealthy substance use and related conditions as described in the (US) Institute of Medicine report, Improving the Quality of Healthcare for Mental Health and Substance Use Conditions (Washington, DC: National Academies Press, 2006). Such articles address the quality of care and of health services. Although the journal also welcomes submissions that address these conditions in addiction speciality-treatment settings, the journal is particularly interested in including articles that address unhealthy use outside these settings, including experience with novel models of care and outcomes, and outcomes of research-practice collaborations.
Although Addiction Science & Clinical Practice is generally not an outlet for basic science research, we will accept basic science research manuscripts that have clearly described potential clinical relevance and are accessible to audiences outside a narrow laboratory research field.
Addiction Science & Clinical Practice was previously published by NIDA and the journal's back content can be viewed here - http://www.ncbi.nlm.nih.gov/pmc/journals/1002/
All articles published by Addiction Science & Clinical Practice are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.
As authors of articles published in Addiction Science & Clinical Practice you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BioMed Central license agreement.
For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BioMed Central can accommodate non-standard copyright lines. Please contact us if further information is needed.
Open access publishing is not without costs. Addiction Science & Clinical Practice therefore levies an article-processing charge of £1370/$2145/€1745 for each article accepted for publication. If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
BioMed Central provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and policy support page to view our list of research funders and institutions that provide funding for APCs, and to learn more about our email support service.
US and US funded authors
Please note that US authors, including authors funded by US institutions, can contact our customer services team for further advice on making payment for accepted manuscript article-processing charges (APCs) at email@example.com
All articles published in Addiction Science & Clinical Practice are included in:
- Emerging Sources Citation Index (ESCI)
The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.
We are working closely with relevant indexing services including Web of Science (Thomson Reuters) to ensure that articles published in Addiction Science & Clinical Practice will be available in their databases when appropriate.
Addiction Science & Clinical Practice operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
All manuscripts submitted to Addiction Science & Clinical Practice should adhere to BioMed Central's editorial policies.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Citing articles in Addiction Science & Clinical Practice
Articles in Addiction Science & Clinical Practice should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.
Article citations follow this format:
Authors: Title. Addict Sci Clin Pract [year], [volume number]:[article number].
e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Addict Sci Clin Pract 2009, 1:115.
refers to article 115 from Volume 1 of the journal.
Appeals and complaints
If you wish to appeal a rejection or make a complaint you should, in the first instance, contact the Editor who will provide details of the journal's complaints procedure. For complaints that cannot be resolved with the Editor, the authors should contact the Publisher.
Why publish your article in Addiction Science & Clinical Practice
Addiction Science & Clinical Practice's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.
Speed of publication
Addiction Science & Clinical Practice offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.
Online publication in Addiction Science & Clinical Practice gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).
Promotion and press coverage
Articles published in Addiction Science & Clinical Practice are included in article alerts and regular email updates. Some may be highlighted on Addiction Science & Clinical Practice’s pages and on the BioMed Central homepage.
In addition, articles published in Addiction Science & Clinical Practice may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Addiction Science & Clinical Practice. A list of articles recently press-released by journals published by BioMed Central is available here.
As an author of an article published in Addiction Science & Clinical Practice you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BioMed Central license agreement).
For further information about the advantages of publishing in a journal from BioMed Central, please click here.
The Farmington Consensus
Addiction Science & Clinical Practice adheres to the ethical guidelines for scientific publishing outlined in the Farmington Consensus. The Consensus is a series of ethical guidelines for addiction journals developed in 1997 at the inaugural meeting of the group now known as the International Society of Addiction Journal Editors (ISAJE). The resulting document can be found in draft form here. The purpose of the guidelines is to provide guidance to authors, editors and other individuals on ethical and procedural matters that affect the integrity of scientific publishing in the addiction field. We urge readers, writers, reviewers of Addiction Science & Clinical Practice to study the guidelines, to criticize them, to improve them, and to use them effectively.